Volume 32, Issue 1 (Avicenna Journal of Clinical Medicine-Spring 2025)
Avicenna J Clin Med 2025, 32(1): 64-68 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Dehghaniathar R, Moradi A, Dianati A. Association of Smoking and Opioid Consumption with Bladder Cancer Staging. Avicenna J Clin Med 2025; 32 (1) :64-68
URL: http://sjh.umsha.ac.ir/article-1-3203-en.html
URL: http://sjh.umsha.ac.ir/article-1-3203-en.html
1- Department of Urology, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences. Tehran, Iran , dr.dehghaniathar@yahoo.com
2- Department of Urology, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences. Tehran, Iran
2- Department of Urology, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences. Tehran, Iran
Abstract: (104 Views)
Background and Objective: Bladder cancer is the 10th most common cancer worldwide, affecting six million people annually. In recent studies, the relationship of this cancer with opioid consumption and smoking was demonstrated. The present study aimed to assess the frequency of smoking and opioid use in patients with bladder cancer and the relationship between these risk factors and bladder cancer staging.
Materials and Methods: This multi-central cross-sectional study was performed on all bladder cancer patients who were referred to Firoozgar and Rasoul-e-Akram Hospitals (Tehran, Iran) from 2018 to 2022. The patient’s characteristics and habitual history, including smoking and opioid consumption, were analyzed. Opioid use and smoking correlation with cancer stage and the correlation between age and tumor stage were evaluated by Chi-square tests and point biserial correlation coefficient test, respectively.
Results: A total of 499 patients were included. The mean age was 69.13 years. Regarding gender, 83.97% of patients were male. Moreover, 36.67% and 19.44% of subjects had a history of smoking and opioid consumption, respectively. In terms of stage, 19.04%, 27.45%, 25.85%, and 27.66% had been diagnosed with stages 1, 2, 3, and 4 bladder cancer. Smoking, as well as opioid use, had a significant relationship with the bladder cancer stage (P<0.001).
Conclusion: Data from 499 patients were analyzed, and the results indicated no significant relationship between the gender of patients and the stage of bladder cancer. Furthermore, smoking and opioid consumption displayed a significant relationship with the stage of bladder cancer. In the current study, smoking and opioid consumption demonstrated a significant relationship with the stage of bladder cancer.
Materials and Methods: This multi-central cross-sectional study was performed on all bladder cancer patients who were referred to Firoozgar and Rasoul-e-Akram Hospitals (Tehran, Iran) from 2018 to 2022. The patient’s characteristics and habitual history, including smoking and opioid consumption, were analyzed. Opioid use and smoking correlation with cancer stage and the correlation between age and tumor stage were evaluated by Chi-square tests and point biserial correlation coefficient test, respectively.
Results: A total of 499 patients were included. The mean age was 69.13 years. Regarding gender, 83.97% of patients were male. Moreover, 36.67% and 19.44% of subjects had a history of smoking and opioid consumption, respectively. In terms of stage, 19.04%, 27.45%, 25.85%, and 27.66% had been diagnosed with stages 1, 2, 3, and 4 bladder cancer. Smoking, as well as opioid use, had a significant relationship with the bladder cancer stage (P<0.001).
Conclusion: Data from 499 patients were analyzed, and the results indicated no significant relationship between the gender of patients and the stage of bladder cancer. Furthermore, smoking and opioid consumption displayed a significant relationship with the stage of bladder cancer. In the current study, smoking and opioid consumption demonstrated a significant relationship with the stage of bladder cancer.
References
1. The International Agency for Research on Cancer. GLOBOCAN 2022. Link
2. Faegh A, Jahani S, Chinisaz F, Baghaei H, Majidi Zolbin M. Stem cell therapy for bladder regeneration: A comprehensive systematic review. Regen Ther. 2025; 28:191–200. PMID: 39811066 DOI: 10.1016/j.reth.2024.12.005
3. Afshari M, Janbabaei G, Bahrami MA, Moosazadeh M. Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer. PLoS One 2017;12(6): e0178527. PMID: 28586371 DOI: 10.1371/journal.pone.0178527
4. Wong MCS, Fung FDH, Leung C, Cheung WWL, Goggins WB, Ng CF. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep. 2018;8(1):1129. PMID: 29348548 DOI: 10.1038/s41598-018-19199-z
5. Rashidian H, Haghdoost AA, Hadji M, Marzban M, Gholipour M, Zendehdel K. Association between opium use and bladder cancer: A case-control study in a high risk area of Iran. Clin Epidemiol Glob Health. 2021; 11:100772. DOI: 10.1016/j.cegh.2021.100772
6. Rashidian H, Haghdoost AA, Daroudi R, Raadabadi M, Ebadzadeh MR, Zendehdel K. Estimating the prevalence of bladder cancer by stage in Iran as a developing country. Med J Islam Repub Iran. 2022; 36:37. PMID: 36128281 DOI: 10.47176/mjiri.36.37
7. Ahmadi M, Ranjbaran H, Amiri MM, Nozari J, Mirzajani MR, Azadbakht M, et al. Epidemiologic and socioeconomic status of bladder cancer in Mazandaran Province, northern Iran. Asian Pac J Cancer Prev. 2012;13(10):5053–5056. PMID: 23244109 DOI: 10.7314/apjcp.2012.13.10.5053
8. Pishgar F, Amini E, Gohari K, Aminorroaya A, Sheidaei A, Rostamabadi Y, et al. National and subnational mortality of urological cancers in Iran, 1990-2015. Asia Pac J Clin Oncol. 2019;15(2): e43–e48. PMID: 30270510 DOI: 10.1111/ajco.13074
9. Barbosa ALA, Vermeulen SHHM, Aben KK, Grotenhuis AJ, Vrieling A, Kiemeney LA. Smoking intensity and bladder cancer aggressiveness at diagnosis. PLoS One. 2018;13(3): e0194039. PMID: 29570711 DOI: 10.1371/journal.pone.0194039
10. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66(6 Suppl 1):4–34. PMID: 16399414 DOI: 10.1016/j.urology.2005.07.062
11. Abdolahinia Z, Pakmanesh H, Mirzaee M, Bazrafshan A, Bafti MS, Shahesmaeili A. Opium and cigarette smoking are independently associated with bladder cancer: The findings of a matched case -control study. Asian Pac J Cancer Prev. 2021;22(10):3385–3391. DOI:10.31557/APJCP.2021.22.10.3385
12. Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. Int J Epidemiol. 2022;51(3):830–838. PMID: 35244716 DOI: 10.1093/ije/dyac031
13. Koohi F, Salehiniya H. The trend of incidence of bladder cancer in Iran, 2003-2009. Studies Med Sci. 2015;26(1):1-9. Link
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences
Published by UMSHA Press
Journal Tel: +988138380924
Publisher Tel:+988138380548
Website: http://sjh.umsha.ac.ir
Email: s_ journal[at]umsha.ac.ir
